Go Pro
→ Silicon Valley Insider: 'Forget AI Stocks' (From Brownstone Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cel-Sci Corporation stock logo
CVM
Cel-Sci
$1.42
$1.26
$0.89
▼
$13.48
$24.82M0.63212,695 shs66,121 shs
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
$14.34
$12.59
$6.62
▼
$15.35
$1.38B1.23571,861 shs635,483 shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cel-Sci Corporation stock logo
CVM
Cel-Sci
0.00%-7.79%+20.34%0.00%-85.08%
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
0.00%+6.07%+21.84%+55.19%+83.14%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cel-Sci Corporation stock logo
CVM
Cel-Sci
$1.42
$1.26
$0.89
▼
$13.48
$24.82M0.63212,695 shs66,121 shs
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
$14.34
$12.59
$6.62
▼
$15.35
$1.38B1.23571,861 shs635,483 shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cel-Sci Corporation stock logo
CVM
Cel-Sci
0.00%-7.79%+20.34%0.00%-85.08%
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
0.00%+6.07%+21.84%+55.19%+83.14%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cel-Sci Corporation stock logo
CVM
Cel-Sci
0.00
N/AN/AN/A
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
3.00
Buy$26.1782.47% Upside

Current Analyst Ratings Breakdown

Latest MGTX and CVM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2026
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$26.00 ➝ $27.00
8/13/2026
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/17/2026
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/8/2026
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$25.00 ➝ $26.00
7/8/2026
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$20.00
5/26/2026
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
(Data available from 8/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cel-Sci Corporation stock logo
CVM
Cel-Sci
N/AN/AN/AN/A$2.32 per shareN/A
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
$81.39M16.92N/AN/A($0.07) per share-204.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cel-Sci Corporation stock logo
CVM
Cel-Sci
-$25.41M-$9.77N/AN/AN/AN/A-250.83%-125.06%N/A
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
-$114.20M$0.7120.20N/AN/A19.87%283.85%29.39%11/12/2026 (Estimated)

Latest MGTX and CVM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q3 2026
Cel-Sci Corporation stock logo
CVM
Cel-Sci
N/A-$0.47N/A-$0.47N/AN/A
8/13/2026Q2 2026
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
-$0.4583$1.71+$2.1683$1.71$0.70 million$321.43 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cel-Sci Corporation stock logo
CVM
Cel-Sci
N/AN/AN/AN/AN/A
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cel-Sci Corporation stock logo
CVM
Cel-Sci
0.35
1.48
1.42
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
0.46
3.76
3.76

Institutional Ownership

CompanyInstitutional Ownership
Cel-Sci Corporation stock logo
CVM
Cel-Sci
12.08%
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
67.48%

Insider Ownership

CompanyInsider Ownership
Cel-Sci Corporation stock logo
CVM
Cel-Sci
14.06%
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
7.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cel-Sci Corporation stock logo
CVM
Cel-Sci
4317.48 million15.02 millionOptionable
MeiraGTx Holdings PLC stock logo
MGTX
MeiraGTx
30096.04 million88.94 millionOptionable

Recent News About These Companies

Tocqueville Asset Management L.P. Makes New $1.05 Million Investment in MeiraGTx Holdings PLC $MGTX
August 21 at 5:35 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-tocqueville-asset-management-lp-makes-new-105-million-investment-in-meiragtx-holdings-plc-mgtx-2026-08-21/
What Does MeiraGTx (NASDAQ:MGTX) Reveal About Nasdaq Biotech Trends?
August 19, 2026  |  kalkinemedia.comK
Insider Selling: MeiraGTx (NASDAQ:MGTX) CEO Sells $859,320.00 in Stock
August 19, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mgtx-insider-buying-and-selling-2026-08-19/
Alexandria Forbes Sells 62,000 Shares of MeiraGTx (NASDAQ:MGTX) Stock
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/alexandria-forbes-sells-62000-shares-of-meiragtx-nasdaqmgtx-stock-2026-08-18/
MeiraGTx (NASDAQ:MGTX) Price Target Raised to $27.00
August 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30965399
FY2026 EPS Estimates for MeiraGTx Increased by HC Wainwright
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/fy2026-eps-estimates-for-meiragtx-increased-by-hc-wainwright-2026-08-17/
Johnson & Johnson Takes $89.72 Billion Position in MeiraGTx Holdings PLC $MGTX
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-johnson-johnson-takes-8972-billion-position-in-meiragtx-holdings-plc-mgtx-2026-08-16/
MeiraGTx (NASDAQ:MGTX) Trading Up 8.4% on Earnings Beat
August 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30963198
What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal?
August 15, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/could-meiragtx-holdings-mgtx-hires-231214147.html
MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to "Strong-Buy" Rating
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/meiragtx-nasdaqmgtx-upgraded-by-zacks-research-to-strong-buy-rating-2026-08-15/
MeiraGTx (NASDAQ:MGTX) Raised to Buy at Wall Street Zen
August 15, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30962017
MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Buy" Rating
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/meiragtx-nasdaqmgtx-upgraded-by-wall-street-zen-to-buy-rating-2026-08-15/
MeiraGTx (NASDAQ:MGTX) Shares Gap Up on Earnings Beat
August 15, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30961201
MeiraGTx (NASDAQ:MGTX) Trading 8.4% Higher Following Strong Earnings
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/meiragtx-nasdaqmgtx-trading-84-higher-following-strong-earnings-2026-08-14/
MeiraGTx (NASDAQ:MGTX) Given New $27.00 Price Target at Royal Bank Of Canada
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/meiragtx-nasdaqmgtx-given-new-2700-price-target-at-royal-bank-of-canada-2026-08-14/
MeiraGTx Swings to Q2 Profit, Revenue Rises
August 14, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/meiragtx-swings-q2-profit-revenue-121702811.html
Sei Investments Co. Buys Shares of 99,627 MeiraGTx Holdings PLC $MGTX
August 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-sei-investments-co-buys-shares-of-99627-meiragtx-holdings-plc-mgtx-2026-08-14/
Head-To-Head Survey: Biomea Fusion (NASDAQ:BMEA) & MeiraGTx (NASDAQ:MGTX)
August 14, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30960814
MeiraGTx (NASDAQ:MGTX) Releases Quarterly Earnings Results, Beats Expectations By $2.17 EPS
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/meiragtx-nasdaqmgtx-releases-quarterly-earnings-results-beats-expectations-by-217-eps-2026-08-13/
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates
August 13, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2974148/meiragtx-holdings-plc-mgtx-q2-earnings-and-revenues-surpass-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2974148
MeiraGTx (NASDAQ:MGTX) Shares Gap Up on Strong Earnings
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/meiragtx-nasdaqmgtx-shares-gap-up-on-strong-earnings-2026-08-13/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cel-Sci stock logo

Cel-Sci NYSEAMERICAN:CVM

$1.42 0.00 (0.00%)
As of 08/21/2026 04:10 PM Eastern

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers. It is also developing products based on its proprietary technology Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer. In addition, the company's product pipeline includes CEL-2000; CEL-4000; and CEL-5000, which are LEAPS-based product candidates in preclinical trials for the treatment of rheumatoid arthritis disease. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.

MeiraGTx stock logo

MeiraGTx NASDAQ:MGTX

$14.34 0.00 (0.00%)
As of 08/21/2026 04:00 PM Eastern

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. The company was incorporated in 2015 and is based in New York, New York.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas